Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 4,353–4,360 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
XOMA Royalty Corporation HIL-214 - (NOR-213) GI.1/GII.4 virus-like particle (VLP) vaccine Phase 2 Trial Discontinued oral Gastroenterology
XOMA Royalty Corporation RZ402 Diabetic macular edema (DME) Phase 2 Data Released Oral Opthalmic
XOMA Royalty Corporation XOMA 213 Hyperprolactinemia Phase 2 Trial Completed Intravenous Endocrinology
XORTX Therapeutics Inc. XRx-101 Acute kidney injury associated with Coronavirus / COVID-19 infection. Phase 2 Ongoing Oral COVID-19
XORTX Therapeutics Inc. XRx-008 Polycystic Kidney Disease (ADPKD) Phase 2 Ongoing Oral Genetic Disorder
XTL Biopharmaceuticals Ltd. hCDR1 Systemic Lupus Erythematosus (SLE) Phase 2 Subcutaneous Immunology
Y-mAbs Therapeutics Inc. DANYELZA (Naxitamab) - (201) High-risk neuroblastoma (HR-NB) commonly Phase 2 Data Released Intravenous Oncology
Zai Lab Limited Efgartigimod - (ADHERE) Chronic inflammatory demyelinating polyneuropathy (CIDP) BLA Filing Data Released Intravenous Neurology